Search research articles
Contact Us
Filters
Showing results (81-90 of 119) with videos related to
Page
of 12
Sort By:
BMJ Open
|
May 8, 2020
Construction of the secondary care administrative records frailty (SCARF) index and validation on older women with operable invasive breast cancer in England and Wales: a cohort study
Yasmin Jauhari, Melissa Ruth Gannon, David Dodwell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 3, 2023
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes
Francesca Holt, Jake Probert, Sarah C Darby, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 24, 2021
Tricks and tips for target volume definition and delineation in breast cancer: Lessons learned from ESTRO breast courses
Orit Kaidar-Person, Birgitte V Offersen, Liesbeth Boersma, et al.
BMJ Open
|
May 14, 2026
Age, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data
Sarah Blacker, Diana R Withrow, Jemma M Boyle, et al.
The Oncologist
|
May 17, 2011
Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer
David Miles, Henri Roché, Miguel Martin, et al.
Ophthalmology. Retina
|
May 4, 2019
Physiologic and Psychologic Risk Factors in Central Serous Chorioretinopathy
Ahmad M Mansour, Mona Koaik, Luiz H Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer
James E Lester, David Dodwell, Omprakash P Purohit, et al.
Diagnostic and Prognostic Research
|
April 8, 2026
Protocol for the development and validation of a risk score to predict risk of adverse events associated with systemic anti-cancer treatment in late-stage lung cancer: Lung Cancer Improved Decisions (LUCID)
Ofran Almossawi, Luke Steventon, Ruth Keogh, et al.
The Lancet. Oncology
|
October 18, 2017
Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial
Robert Coleman, Andrew Hall, Joan Albanell, et al.
The Lancet. Oncology
|
September 7, 2016
30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study
Michael Wallington, Emma B Saxon, Martine Bomb, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 119) with videos related to
Sort By:
Page
of 12
BMJ Open
|
May 8, 2020
Construction of the secondary care administrative records frailty (SCARF) index and validation on older women with operable invasive breast cancer in England and Wales: a cohort study
Yasmin Jauhari, Melissa Ruth Gannon, David Dodwell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 3, 2023
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes
Francesca Holt, Jake Probert, Sarah C Darby, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 24, 2021
Tricks and tips for target volume definition and delineation in breast cancer: Lessons learned from ESTRO breast courses
Orit Kaidar-Person, Birgitte V Offersen, Liesbeth Boersma, et al.
BMJ Open
|
May 14, 2026
Age, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data
Sarah Blacker, Diana R Withrow, Jemma M Boyle, et al.
The Oncologist
|
May 17, 2011
Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer
David Miles, Henri Roché, Miguel Martin, et al.
Ophthalmology. Retina
|
May 4, 2019
Physiologic and Psychologic Risk Factors in Central Serous Chorioretinopathy
Ahmad M Mansour, Mona Koaik, Luiz H Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer
James E Lester, David Dodwell, Omprakash P Purohit, et al.
Diagnostic and Prognostic Research
|
April 8, 2026
Protocol for the development and validation of a risk score to predict risk of adverse events associated with systemic anti-cancer treatment in late-stage lung cancer: Lung Cancer Improved Decisions (LUCID)
Ofran Almossawi, Luke Steventon, Ruth Keogh, et al.
The Lancet. Oncology
|
October 18, 2017
Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial
Robert Coleman, Andrew Hall, Joan Albanell, et al.
The Lancet. Oncology
|
September 7, 2016
30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study
Michael Wallington, Emma B Saxon, Martine Bomb, et al.
Page
of 12